Publications by authors named "Rachelle Dillon"

Claim this Profile
U
US Clinical Practice Patterns of Intravesical Chemotherapy for Bacillus Calmette-Guérin-Unresponsive and Bacillus Calmette-Guérin-Exposed Nonmuscle-Invasive Bladder Cancer.
Mohamad Abou Chakra, Neal D Shore, Rachelle Dillon, Michael A O'Donnell

Urol Pract· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply by Authors.
Mohamad Abou Chakra, Neal D Shore, Rachelle Dillon, Michael A O'Donnell

Urol Pract· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vivo evidence supporting a metastasis suppressor role for Stard13 (Dlc2) in ErbB2 (Neu) oncogene induced mouse mammary tumors.
Pratima Basak, Heather Leslie, Rachelle L Dillon, William J Muller, Afshin Raouf

Genes Chromosomes Cancer· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DeBouganin Diabody Fusion Protein Overcomes Drug Resistance to ADCs Comprised of Anti-Microtubule Agents.
Shilpa Chooniedass, Rachelle L Dillon, Arjune Premsukh, Peter J Hudson, Gregory P Adams

Molecules· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trastuzumab-deBouganin Conjugate Overcomes Multiple Mechanisms of T-DM1 Drug Resistance.
Rachelle L Dillon, Shilpa Chooniedass, Arjune Premsukh, Gregory P Adams, Joycelyn Entwistle

J Immunother· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dlc1 interaction with non-muscle myosin heavy chain II-A (Myh9) and Rac1 activation.
Mohammad G Sabbir, Rachelle Dillon, Michael R A Mowat

Biol Open· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human Leukocyte Antigen-Presented Macrophage Migration Inhibitory Factor Is a Surface Biomarker and Potential Therapeutic Target for Ovarian Cancer.
Andrea M Patterson, Saghar Kaabinejadian, Curtis P McMurtrey, Wilfried Bardet, Ken W Jackson, Rachelle L Dillon

Mol Cancer Ther· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Deleted in Liver Cancer 1 (Dlc1) tumor suppressor is haploinsufficient for mammary gland development and epithelial cell polarity.
Pratima Basak, Rachelle Dillon, Heather Leslie, Afshin Raouf, Michael R A Mowat

BMC Cancer· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Distinct biological roles for the akt family in mammary tumor progression.
Rachelle L Dillon, William J Muller

Cancer Res· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Akt1 and akt2 play distinct roles in the initiation and metastatic phases of mammary tumor progression.
Rachelle L Dillon, Richard Marcotte, Bryan T Hennessy, James R Woodgett, Gordon B Mills

Cancer Res· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An EGR2/CITED1 transcription factor complex and the 14-3-3sigma tumor suppressor are involved in regulating ErbB2 expression in a transgenic-mouse model of human breast cancer.
Rachelle L Dillon, Stephen T Brown, Chen Ling, Toshishiro Shioda, William J Muller

Mol Cell Biol· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HER2/neu-induced mammary tumorigenesis and angiogenesis are reduced in cyclooxygenase-2 knockout mice.
Louise R Howe, Sung-Hee Chang, Kelly C Tolle, Rachelle Dillon, Lawrence J T Young

Cancer Res· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis